Grupo Médico Camino S.C.

México, Mexico CITY (federal District) 03600

0 studies enrolling now · 2 studies all time

What they study most

Multiple Sclerosis, Primary Progressive, Relapsing Multiple Sclerosis

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis — Running, not enrolling
• Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS) — Running, not enrolling